South_agency | E+ | Getty Images There has been a nationwide increase in “phantom hacker” scams, a type of fraud “significantly impacting senior citizens,” who often lose their entire bank, savings, retirement or investment accounts to such crime, according to the FBI. “Phantom hacker” scams are an evolution of tech support scams, a type of…

Check out the companies making headlines before the bell. Wyndham Hotels & Resorts , Choice Hotels — Choice Hotels dropped 2.3% after the hotel chain proposed buying Wyndham Hotels & Resorts for $90 per share, valuing Wyndham at roughly $7.8 billion. Wyndham’s stock popped 15% on news of the offer. Bank of America — The…

Brian Moynihan, CEO of Bank of America Heidi Gutman | CNBC Bank of America topped estimates for third-quarter profit on Tuesday on stronger-than-expected interest income. Here’s what the company reported: Earnings per share: 90 cents vs. expected 82 cent estimate from LSEG, formerly known as Refinitiv Revenue: $25.32 billion, vs. expected $25.14 billion Profit rose…

David Solomon, chief executive officer of Goldman Sachs Group Inc., at the Goldman Sachs Financial Services Conference in New York, Dec. 6, 2022. Michael Nagle | Bloomberg | Getty Images Goldman Sachs is scheduled to report third-quarter earnings before the opening bell Tuesday. Here’s what Wall Street expects: Earnings: $5.31 a share, according to LSEG,…

Market Movers rounded up the latest reactions to Lululemon from investors and analysts following the athleisure clothing company’s ascension to the S & P 500 effective Wednesday. The i ndex change was announced Friday . Lululemon is replacing Activision Blizzard, which was acquired by Microsoft Friday in a much-delayed, $69 billion deal. LULU stock is…

Check out the companies making the biggest moves midday. Lululemon — Shares of the athleisure clothing company surged more than 10% after S & P Dow Jones Indices announced that the company’s stock will be added to the S & P 500 on Wednesday. Lululemon will replace Activision Blizzard following the completion of its takeover…

Check out the companies making headlines before the bell. Pfizer , Moderna , BioNTech — Shares of Pfizer dropped 1.3% after the company slashed its full-year revenue guidance by $9 billion, noting waning demand for its Covid treatment and vaccine. Following the guidance cut, Jefferies upgraded Pfizer on Monday, citing an attractive buying opportunity. Vaccine…

Two experts see major challenges facing the adoption of new obesity drugs. Dr. Kavita Patel, a physician and NBC News medical contributor, believes fresh data from Novo Nordisk on Ozempic’s ability to delay the progression of chronic kidney disease is among the strongest supporting evidence for secondary uses of the drug. However, she considers data…

It may be a risk-taker’s market. Investor and personal finance author Ric Edelman believes it’s a practical strategy to take chips off the table right now. “It comes down to behavioral finance. It comes down to human emotion,” the Edelman Financial Engines founder told CNBC’s “ETF Edge” this week. “Do you have the stomach? Does…

Market Movers rounded up the latest reactions on UnitedHealth Group from investors and analysts. The pros, including Jim Cramer , discussed the health-care giant after it released third-quarter adjusted earnings of $6.56 per share on revenue of $92.4 billion , both of which beat analysts’ estimates. UnitedHealth closed the trading day up 2.6%, ending at…